CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives
Catalysis Science & Technology · 2026
DOI: 10.1039/d6cy01228k ↗Kurz gefasst
Fachartikel in der Zeitschrift Catalysis Science & Technology, 2026. Verfasst von Kamal Prasad Regmi und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Gefördert von: National Research Foundation.
Abstract (Originalsprache)
CYP109J6 exhibits an unusual reductive activity, selectively converting trifluoromethylated coumarins into 3,4-dihydrocoumarins. Experimental and computational analyses highlight a noncanonical catalytic function of bacterial cytochrome P450 enzymes.
Förderung
- National Research Foundation
Zitieren
APA
Regmi, K. P., Paudel, P., Park, H., Kim, M., Han, S., Kim, H., & Oh, T. (2026). CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives. Catalysis Science & Technology. https://doi.org/10.1039/d6cy01228k
Vancouver
Regmi KP, Paudel P, Park H, Kim M, Han S, Kim H, et al. CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives. Catalysis Science & Technology. 2026. doi:10.1039/d6cy01228k
BibTeX
@article{Regmi2026,
author = {Regmi, Kamal Prasad and Paudel, Prakash and Park, Hye-Soo and Kim, Min-Su and Han, So-Ra and Kim, Hwa-Jung and Oh, Tae-Jin},
title = {CYP109J6-mediated reductive biotransformation of trifluoromethylated coumarin derivatives},
journal = {Catalysis Science & Technology},
year = {2026},
doi = {10.1039/d6cy01228k}
}
EUVIMED